Velusetrag for the Treatment of Chronic Intestinal Pseudo-Obstruction (CIPO).

Clinical trial NCT05724069 · COMPLETED

Trial details

NCT number: NCT05724069
Sponsor: Alfasigma S.p.A.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Intestinal Pseudo-obstruction

Start date: 2021-12-15
Primary completion: 2023-04-12
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.